Presentation from hbm week workshops available for download
Workshop HBM EXPERIENCES IN EUROPE
During the workshop representatives of countries all over Europe have presented their experiences and challenges as well as policy implications regarding their bio-monitoring surveillance program. Experiences with who, partnerships with the industry and experiences of the ngo’s have been addressed.
Hbm surveillance program geres in Germany and impact on environmental policy and vci – bmu initiative: partnership between industry and government
Marike Kolossa-Gehring, Uba – Geres
Hbm surveillance program in Slovenia
Milena Horvat, Jožef Stefan Institute
Hbm surveillance program in france: how to define the substances of interest
Nadine Frery - Institut De Veille Sanitaire - Departement Sante Environnement
Public interest groups’ work on hbm and some perspectives on the european and
international policy landscape
Lisette Van Vliet - Health & Environment Alliance (Heal), Belgium
Hbm surveillance program for pcbs and heavy metals in the Czech Republic
Milena Czerna - National Institute Of Public Health, Czech Republic
Hbm Surveillance Program In Belgium, Flanders: From Biomarker Results To Policy
Greet Schoeters, Vito, Belgium
National hbm surveillance program in Spain
Argelia Castano - Instituto De Salud Carlos Iii, Majadahonda, Madrid
Involvement of cophes/democophes in the development of the Parma hbm indicators of the WHO-Europe Environment And Health Process
Andrey Egorov - World Health Organization, European Centre For Environment And Health, Bonn
Workshop on Quality of Analytical Data in HBM
During the workshop experts have presented their experiences in quality- and inter-comparability aspects of analytical data focused on Human Biomonitoring.
Sops (german dfg compendium of analytical methods)
Schindler, Koch And Angerer. ipa. Bochum, Germany
Analysis of phthalates metabolites in urine.
Antonia Calafat. cdc, Atlanta Usa
Analysis of cd and creatinine in urine
Mirja Kiilunen. Finnish Institute Of Occupational Health Chemical Safety. Finland
Qmeqas experiences with hair and urine.
Alain Leblanc. Centre De Toxicology. Inspq Quebec. (t.b. c.)
Statistical implications of inter-lab variability for measurements in democophes.
Greet Schoeters, Elly Den Hond. Vito . Belgium.
“European health examination survey – challenges in the standardization of the collection and analysis of the blood samples”.
Hanna Tolonen . National Institute For Health And Welfare. Helsinki. Finland.
Workshop on Bisphenol A, triclosan and parabens in HBM
During the workshop experts have presented their experiences and challenges as well as policy implications regarding the biomarkers for these compounds.
Main challenges related to the biomarkers for bisphenol a and triclosan exposure
Antonia Calafat, Cdc –Atlanta Usa
Results and assessment of bisphenol a measurements on children in geres iv
Marike Kolossa-Gehring, Uba – Geres , Germany
Exposure sources and human levels of bisphenol a and triclosan in Belgium
Tinne Geens, University Of Antwerp, Belgium
Results of bpa and parabens measurements in hbm studies in Denmark
Hanne Frederiksen - University Hospital, Dept. Growth And Reproduction
Health effects of early, low-level exposure to triclosan in children: triclosan exposure and allergy in 10-year old norwegian children
Randi Bertelsen, National Institute For Environmental Health Sciences , North Carolina, Usa
Bisphenol a: from science to policy
Leo Goeyens, Vub And High Councel Of Health – Working Group Bpa , Belgium
Ngo views on policy responses to bpa, parabens and triclosans. using hbm data to reduce the public’s exposure
Lisette Van Vliet - Health & Environment Alliance (Heal)
Urinary concentrations of bisphenol a in samples of the german environmental specimen bank from 1995 to 2009: a retrospective exposure assessment
Holger Koch, Ipa – Germany
Workshop HBM and indoor/outdoor air quality
Different themes in environment and health (outdoor air quality, indoor air quality and human biomonitoring) have reached at this stage different levels of maturity.
During the workshop experts have discussed how the different networks (outdoor, indoor an human biomonitoring) have defined exposure/reference values, how these values have been used to communicate with health care professionals, scientists, policy makers or a wider public, how did it worked out and how each network could benefit from each other.
Case study: role of the EU reference value in the association between PM10 air pollution and infant mortality in Belgium
Hans Scheers, Katholieke Universiteit van Leuven
Case study: Indoor air quality, human biomonitoring and health in Luxembourg
Ralph Baden, Ministère de la Santé du Luxembourg et INTERCIP
Case study: Aphecom: WHO limits and health impact
Catherine Bouland, University of Brussels, Institute of Public Health
Case study: The need for standardised guideline values to interpret results from inddor air pollution – Priscilla Declercq, Sandrine Bladt, IBGE
Principles for standard setting in EU and US
Bert Brunekreef, IRAS, Universiteit Utrecht
Approaches to define IAQ reference values in Germany
Johannes Schmidt, Institut für Baubiologie + Oekologie IBN
Human biomonitoring as a tool to develop reference values and explore exposure pathways
Marike Kolossa-Gehring, UBA – GerES